Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimas Echeverria

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Nucleic Acids Research|April 13, 2024
Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivoSamantha L Sarli, Hassan H Fakih, Karen Kelly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 20, 2024
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's diseaseChantal M Ferguson, Samuel Hildebrand, Bruno M D C Godinho, et al.
Nucleic Acid Therapeutics|March 12, 2026
Conjugated Antisense Oligonucleotides for Skipping of Duchenne Muscular Dystrophy Exon 53: A Cautionary StudyEmma T Groenwold, Alicia Montulet, Tiberiu Stan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2018
Transvascular Delivery of Hydrophobically Modified siRNAs: Gene Silencing in the Rat Brain upon Disruption of the Blood-Brain BarrierBruno M D C Godinho, Nils Henninger, James Bouley, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Molecular Therapy. Nucleic Acids|September 5, 2024
Identification of selective and non-selective <i>C9ORF72</i> targeting <i>in vivo</i> active siRNAsJames W Gilbert, Zachary Kennedy, Bruno M D C Godinho, et al.
Research Square|May 2, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing <i>in vivo</i>Han Zhang, Karen Kelly, Jonathan Lee, et al.
Molecular Therapy. Nucleic Acids|July 7, 2022
PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAsBruno M D C Godinho, Emily G Knox, Samuel Hildebrand, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitisKyounghee Min, Batuhan Yenilmez, Mark Kelly, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Nucleic Acids Research|April 13, 2024
Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivoSamantha L Sarli, Hassan H Fakih, Karen Kelly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 20, 2024
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's diseaseChantal M Ferguson, Samuel Hildebrand, Bruno M D C Godinho, et al.
Nucleic Acid Therapeutics|March 12, 2026
Conjugated Antisense Oligonucleotides for Skipping of Duchenne Muscular Dystrophy Exon 53: A Cautionary StudyEmma T Groenwold, Alicia Montulet, Tiberiu Stan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 26, 2018
Transvascular Delivery of Hydrophobically Modified siRNAs: Gene Silencing in the Rat Brain upon Disruption of the Blood-Brain BarrierBruno M D C Godinho, Nils Henninger, James Bouley, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Molecular Therapy. Nucleic Acids|September 5, 2024
Identification of selective and non-selective <i>C9ORF72</i> targeting <i>in vivo</i> active siRNAsJames W Gilbert, Zachary Kennedy, Bruno M D C Godinho, et al.
Research Square|May 2, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing <i>in vivo</i>Han Zhang, Karen Kelly, Jonathan Lee, et al.
Molecular Therapy. Nucleic Acids|July 7, 2022
PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAsBruno M D C Godinho, Emily G Knox, Samuel Hildebrand, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitisKyounghee Min, Batuhan Yenilmez, Mark Kelly, et al.
Pageof 9